Overview

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
Imiquimod 5% cream in the treatment of external genital or perianal warts in HIV+ patients
Phase:
Phase 4
Details
Lead Sponsor:
MEDA Pharma GmbH & Co. KG
Collaborator:
ORION Sante
Treatments:
Imiquimod